GC Biopharma Successfully Launches the World’s First Recombinant Anthrax Vaccine: BARYTHRAX inj. GC Biopharma announces the shipment of BARYTHRAX inj., the world's first recombinant anthrax vaccine, enhancing public health defense globally.

GC Biopharma Successfully Launches the World’s First Recombinant Anthrax Vaccine: BARYTHRAX inj. #South_Korea #GC_Biopharma #Yongin #Anthrax_Vaccine #BARYTHRAX_inj.

GC Biopharma's Breakthrough Anthrax Vaccine BARYTHRAX Shows Promising Safety and Efficacy GC Biopharma announces successful Phase 2 data for BARYTHRAX, the world's first recombinant anthrax vaccine, showcasing safety and strong immune response.

GC Biopharma's Breakthrough Anthrax Vaccine BARYTHRAX Shows Promising Safety and Efficacy #South_Korea #GC_Biopharma #Yongin #BARYTHRAX #Anthrax_Vaccine

GC Biopharma Pioneers Anthrax Vaccine Approval, Sets New Safety Standards GC Biopharma's innovative anthrax vaccine, BARYTHRAX, gains approval in South Korea, marking a breakthrough in vaccine safety and efficacy.

GC Biopharma Pioneers Anthrax Vaccine Approval, Sets New Safety Standards #South_Korea #GC_Biopharma #Yongin #BARYTHRAX #Anthrax_Vaccine